Literature DB >> 16227302

Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells.

Pascale Massin1, Pierre Rodrigues, Monica Marasescu, Sylvie van der Werf, Nadia Naffakh.   

Abstract

Reverse genetics techniques to rescue influenza viruses have thus far been based on the use of a human polymerase I (PolI) promoter to direct the synthesis of the eight viral RNAs. They can only be used on cells from primate origin due to the species specificity of the PolI promoter. Here we report the cloning of the chicken PolI promoter sequence and the generation of recombinant influenza virus upon transfection of bidirectional PolI/PolII plasmids in avian cells. Potential contributions of this new reverse genetics system in the fields of influenza virus research and influenza vaccine production are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227302      PMCID: PMC1262576          DOI: 10.1128/JVI.79.21.13811-13816.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

Review 1.  Novel generations of influenza vaccines.

Authors:  George Kemble; Harry Greenberg
Journal:  Vaccine       Date:  2003-05-01       Impact factor: 3.641

2.  Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  Influenza vaccines generated by reverse genetics.

Authors:  K Subbarao; J M Katz
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

5.  Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin.

Authors:  Astrid Flandorfer; Adolfo García-Sastre; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding.

Authors:  Subrata Barman; Lopa Adhikary; Alok K Chakrabarti; Carl Bernas; Yoshihiro Kawaoka; Debi P Nayak
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.

Authors:  Ervin Fodor; Mandy Crow; Louise J Mingay; Tao Deng; Jane Sharps; Pierre Fechter; George G Brownlee
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  The M1 matrix protein controls the filamentous phenotype of influenza A virus.

Authors:  C J Elleman; W S Barclay
Journal:  Virology       Date:  2004-03-30       Impact factor: 3.616

9.  Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments.

Authors:  Emmie de Wit; Monique I J Spronken; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

10.  Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes.

Authors:  Laura M Burleigh; Lesley J Calder; John J Skehel; David A Steinhauer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

View more
  39 in total

1.  An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase.

Authors:  Andrew Mehle; Jennifer A Doudna
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

Review 2.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.

Authors:  Yong Liu; Kun Qin; Geng Meng; Jinfang Zhang; Jianfang Zhou; Guangyu Zhao; Ming Luo; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2013-02-22       Impact factor: 5.157

4.  Structural basis of transcription initiation by bacterial RNA polymerase holoenzyme.

Authors:  Ritwika S Basu; Brittany A Warner; Vadim Molodtsov; Danil Pupov; Daria Esyunina; Carlos Fernández-Tornero; Andrey Kulbachinskiy; Katsuhiko S Murakami
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

5.  NP body domain and PB2 contribute to increased virulence of H5N1 highly pathogenic avian influenza viruses in chickens.

Authors:  Tatsuya Tada; Koutaro Suzuki; Yu Sakurai; Masanori Kubo; Hironao Okada; Toshihiro Itoh; Kenji Tsukamoto
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

6.  Alternative reverse genetics system for influenza viruses based on a synthesized swine 45S rRNA promoter.

Authors:  Kai Wang; Qi Huang; Zhiwei Yang; Kezong Qi; Hongmei Liu; Hongjun Chen
Journal:  Virus Genes       Date:  2017-04-22       Impact factor: 2.332

7.  Evaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells.

Authors:  Florian Krammer; Jens Pontiller; Christopher Tauer; Dieter Palmberger; Andreas Maccani; Martina Baumann; Reingard Grabherr
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.752

8.  Investigation of influenza virus polymerase activity in pig cells.

Authors:  Olivier Moncorgé; Jason S Long; Anna V Cauldwell; Hongbo Zhou; Samantha J Lycett; Wendy S Barclay
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 9.  Designing vaccines for pandemic influenza.

Authors:  Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

10.  Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice.

Authors:  Thierry Rolling; Iris Koerner; Petra Zimmermann; Kristian Holz; Otto Haller; Peter Staeheli; Georg Kochs
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.